Abiopharma

News list

Director Babcock Beverley A 🟢 acquired 7.0K shares (1 derivative) of OLIN Corp (OLN) at $28.48 Transaction Date: May 01, 2026 | Filing ID: 000002

Full text

News bot May 5, 2026, 5:39 p.m.
🔍 Babcock Beverley A (Director)

Company: OLIN Corp (OLN)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 7,023
Detailed Transactions and Holdings:
- Acquired 2,107 shares of Common Stock $1 par value at $28.48 per share (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,625.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 4,916 shares of Phantom Stock Units (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 38,508.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
Footnotes:
- F1: Represents a portion of the annual director compensation granted under the Olin Corporation Non-Employee Director Deferred Compensation Plan ("Directors Plan").
- F2: Security converts to common stock on a one-to-one basis.
- F3: Represents a portion of the annual director compensation grants that are credited to the reporting person's deferred stock account under the Directors Plan.